Literature DB >> 7060640

Interaction between 5-hydroxytryptamine and other vasoconstrictor substances in the isolated femoral artery of the rabbit; effect of ketanserin (R 41 468).

J M Van Nueten, P A Janssen, A De Ridder, P M Vanhoutte.   

Abstract

Experiments were designed to determine whether or not ketanserin (R 41 468) antagonizes the augmentation by 5-hydroxytryptamine of contractions evoked in isolated arteries by non-adrenergic vasoconstrictor substances. Rings of rabbit femoral arteries were studied under isometric conditions in organ chambers filled with Krebs-Henseleit solution (37 degrees C). Ketanserin, unlike methysergide and LSD, was devoid of agonistic properties. It competitively antagonized contractile responses to 5-hydroxytryptamine and, at higher concentrations, to histamine. 5-Hydroxytryptamine amplified the contractions evoked by threshold concentrations of histamine, angiotensin II and prostaglandin F2 alpha; in all three cases, the amplification was antagonized by comparable concentrations of ketanserin. These experiments indicate that the interaction of 5-hydroxytryptamine with S2-receptors of the vascular smooth muscle cells is essential to allow the expression of the monoamine-induced amplification of the response to other vasoconstrictor substances. The inhibition by ketanserin of the amplifying effect of 5-hydroxytryptamine on vascular responses may help explain the antihypertensive properties of the compound.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7060640     DOI: 10.1016/0014-2999(82)90130-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  20 in total

1.  Release of a neutrophil-derived vasoconstrictor agent which augments platelet-induced contractions of blood vessels in vitro.

Authors:  W C Sessa; K M Mullane
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

2.  Characterization of an endothelial 5-hydroxytryptamine (5-HT) receptor mediating relaxation of the porcine coronary artery.

Authors:  G J Molderings; G Engel; E Roth; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-09       Impact factor: 3.000

3.  Alpha 2-adrenoceptor agonists enhance responses to certain other vasoconstrictor agonists in the rat tail artery.

Authors:  X H Xiao; M J Rand
Journal:  Br J Pharmacol       Date:  1989-03       Impact factor: 8.739

4.  Effects of intra-arterial ketanserin in Raynaud's phenomenon assessed by 99MTc-pertechnetate scintigraphy.

Authors:  J J Kunnen; H P Dahler; J G Doorenspleet; J C van Oene
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

5.  The mechanism of the antihypertensive effects of ketanserin: a comparison with metoprolol.

Authors:  E Casiglia; R Gava; A Semplicini; P Nicolin; A C Pessina
Journal:  Br J Clin Pharmacol       Date:  1986-12       Impact factor: 4.335

6.  Indirect action of 5-hydroxytryptamine on the isolated muscularis mucosae of the guinea-pig oesophagus.

Authors:  Y Kamikawa; Y Shimo
Journal:  Br J Pharmacol       Date:  1983-01       Impact factor: 8.739

7.  An enhancing effect of 5-hydroxytryptamine on electrically evoked atropine-resistant contraction of guinea-pig proximal colon.

Authors:  S Kojima; Y Shimo
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

8.  Mechanisms of the ergonovine-induced vasoconstriction in the rabbit main coronary artery.

Authors:  A Suyama; H Kuriyama
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-07       Impact factor: 3.000

9.  Vasoconstrictor and norepinephrine potentiating action of 5-hydroxykynuramine in the isolated perfused rat kidney: involvement of serotonin receptors and alpha 1-adrenoceptors.

Authors:  K G Charlton; T D Johnson; D E Clarke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-12       Impact factor: 3.000

10.  Facilitating effect of amphetamine on the response of rabbit aortic strips to adrenaline, dopamine and serotonin.

Authors:  B Silvestrini; M Palmery; F Basta; P Valeri
Journal:  J Neural Transm Gen Sect       Date:  1991
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.